Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online February 15, 2007
Diabetes Care 30:1255-1260, 2007
DOI: 10.2337/dc06-2131
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-2131v1
30/5/1255    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leitão, C. B.
Right arrow Articles by Gross, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leitão, C. B.
Right arrow Articles by Gross, J. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

Masked Hypertension, Urinary Albumin Excretion Rate, and Echocardiographic Parameters in Putatively Normotensive Type 2 Diabetic Patients

Cristiane B. Leitão, MD1, Luís H. Canani, MD1, Caroline K. Kramer, MD1, Juliana C. Boza1, Antônio F. Pinotti, MD2 and Jorge L. Gross, MD1

1 Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
2 Cardiology Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

Address correspondence and reprint requests to Cristiane B. Leitão, MD, Serviço de Endocrinologia do Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, Prédio 12, 4° andar, 90035-003 Porto Alegre, RS, Brazil. E-mail: crisbleitao{at}yahoo.com.br

OBJECTIVE—To evaluate the impact of masked hypertension in normotensive type 2 diabetic patients on microvascular complications and echocardiographic parameters.

RESEARCH DESIGN AND METHODS—A cross-sectional study was conducted in 135 normotensive patients with type 2 diabetes. Patients underwent urinary albumin excretion rate (UAER) measurement, echocardiography, and 24-h ambulatory blood pressure monitoring (ABPM). Patients with increased daytime blood pressure levels (≥135/85 mmHg) were classified as having masked hypertension.

RESULTS—The prevalence of masked hypertension was 30% (n = 41). Normotensive and masked hypertensive subjects, based on ambulatory blood pressure, were not different in terms of age, diabetes duration, smoking status, BMI, waist circumference, serum creatinine, glycemic, or lipid profiles. The office systolic blood pressure was higher in those with masked hypertension (127.8 ± 7.5 vs. 122.9 ± 10.2 mmHg, P = 0.003) than in the normotensive group. UAER also was increased in the group with masked hypertension (21.3 µg/min [range 2.5–1,223.5] vs. 8.1 µg/min [1.0–1,143.0], P = 0.001), as was the interventricular septum (1.01 ± 0.15 vs. 0.94 ± 0.13 cm, P = 0.015) and posterior wall (0.96 ± 0.12 vs. 0.90 ± 0.10 cm, P = 0.006) thickness. After adjustments for diabetes duration, sex, smoking, LDL cholesterol, and A1C values, all associations were sustained for daytime systolic blood pressure but not for office systolic blood pressure.

CONCLUSIONS—Type 2 diabetic patients with masked hypertension have higher UAER as well as enlargement of ventricular walls compared with the normotensive patients, according to ABPM. Therefore, ABPM is important to identify this high-risk group so as to be able to take interventionist measures.

Abbreviations: ABPM, ambulatory blood pressure monitoring • UAER, urinary albumin excretion rate


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
M. Panesar, A. Damodar, T. Lindner, S. Anderson, R. Komers, K. Kamoi, H.-H. Parving, and F. Persson
Aliskiren combined with losartan in diabetes and nephropathy.
N. Engl. J. Med., September 4, 2008; 359(10): 1068 - 1069.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Berend and M. Levi
Is it time to celebrate a century of blood pressure management?
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2558 - 2562.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
K. Chavanu, J. Merkel, and A. M. Quan
Role of ambulatory blood pressure monitoring in the management of hypertension
Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 209 - 218.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.